Problem Joints Are Associated With Worse Quality of Life and Work-Productivity Loss in Adults With Hemophilia
Researchers sought to assess the impact of problem joints in patients with hemophilia.
All articles by Lauren Dembeck, PhD
Polatuzumab Vedotin Combined With Chemoimmunotherapy Is Provisionally Cost-Effective in Untreated Diffuse Large B-Cell Lymphoma
Researchers sought to determine whether pola-R-CHP would be cost-effective compared with R-CHOP for first-line treatment of DLBCL.
Race, Ethnicity, Obesity Have No Significant Impact on CAR-T Therapy Efficacy in B-Cell Acute Lymphoblastic Leukemia
Researchers sought to determine whether race, ethnicity, or BMI would have an impact on CAR-T therapy in patients with B-ALL.
Novel Risk Prediction Tool May Identify Patients With Multiple Myeloma at a High Risk of Venous Thromboembolism
Researchers sought to determine whether the PRISM score would be able to identify patients with multiple myeloma at a high risk of VTE.
Prolonged Exportin-1 Inhibition Yields Antileukemic Activity in NPM1-Mutated Acute Myeloid Leukemia
Researchers sought to determine whether prolonged inhibition of exportin-1 would lead to antileukemic activity in an NPM1-mutated AML murine model.
Report on Treatment of Hodgkin Lymphoma in a Patient With Sickle Cell Disease
Researchers reported on treatment of Hodgkin lymphoma in a patient with SCD, utilizing doxorubicin, vinblastine, and dacarbazine.
Novel Machine-Learning Model May Reduce Misdiagnosis in Heparin-Induced Thrombocytopenia
Researchers sought to develop implemented a machine-learning model for the diagnosis of heparin-induced thrombocytopenia.
Associations of Mutations in Spliceosome Genes With Ring Sideroblasts Verified in Myelodysplastic Syndromes
Researchers sought to verify the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in MDS.
Monoclonal Antibody Shows Promise for Treating MPNs in Preclinical Study
Preclinical research suggests that a monoclonal antibody may be effective for treating CALR-mutant myeloproliferative neoplasms.
Circulating Leukocyte DNA Methylation Level May Be a Novel Biomarker in Multiple Myeloma
Researchers sought to determine whether DNA methylation in PBMCs could be a novel biomarker in multiple myeloma.
- Loading...
Loading...
Loading... 
Loading...